Tg Therapeutics (TGTX) Share-based Compensation Growth (5y) (2016 - 2026)
Tg Therapeutics (TGTX) Share-based Compensation Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.99% |
| Dec 31, 2025 | 74.73% |
| Sep 30, 2025 | 8.45% |
| Jun 30, 2025 | 18.74% |
| Mar 31, 2025 | 7.60% |
| Dec 31, 2024 | 10.82% |
| Sep 30, 2024 | 43.57% |
| Jun 30, 2024 | 42.83% |
| Mar 31, 2024 | 40.50% |
| Sep 30, 2023 | 126.50% |
| Jun 30, 2023 | 26.08% |
| Mar 31, 2023 | -0.60% |
| Dec 31, 2022 | 59.65% |
| Sep 30, 2022 | 7.36% |
| Jun 30, 2022 | -21.52% |
| Mar 31, 2022 | -18.76% |
| Dec 31, 2021 | 114.48% |
| Sep 30, 2021 | 37.97% |
| Jun 30, 2021 | 58.14% |
| Mar 31, 2021 | 57.79% |